OptimizeRx Appoints Microsoft Health & Life Sciences COO Mary Varghese Presti to Board, Expanding Strategic Expertise
OPRX sits 28% above its 52-week low of $5.54.
Summary
OptimizeRx appointed Mary Varghese Presti, a Microsoft Health & Life Sciences COO, to its Board of Directors, bringing significant expertise in scaling healthcare technology and M&A integration to support the company's strategic growth initiatives.
Key Events · Executive and Board Changes · OPRX
-
New Independent Director Appointed
Mary Varghese Presti, Corporate VP and COO of Microsoft's Health & Life Sciences, joined the Board on April 3, 2026.
-
Board Expansion and Committee Role
The Board expanded from six to seven members, and Ms. Presti was appointed to the Audit Committee.
-
Strategic Expertise
Ms. Presti brings over 25 years of experience in healthcare, life sciences, and technology, with a focus on scaling platforms, commercializing innovation, and M&A integration.
-
Director Compensation
Ms. Presti will receive an annual cash retainer of $45,000, an annual equity grant valued at approximately $175,000, and an additional $10,000 for Audit Committee service.
Analysis · OPRX · Trade & Services
OptimizeRx has strengthened its Board of Directors with the appointment of Mary Varghese Presti, a highly experienced executive from Microsoft's Health & Life Sciences organization. Her extensive background in scaling healthcare platforms, M&A integration, and driving operational efficiency at major technology and pharmaceutical companies is directly aligned with OptimizeRx's strategic objectives to evolve into a product-led platform with increasing recurring revenue. This appointment, which also expands the board and adds her to the Audit Committee, signals a proactive approach to enhancing governance and accelerating growth.
At the time of this filing, OPRX was trading at $7.07 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $122M. The 52-week trading range was $5.54 to $22.25. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.